124 related articles for article (PubMed ID: 6352657)
1. Clinical experience with ceftazidime in urology in Japan.
Kawamura N
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():65-70. PubMed ID: 6352657
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of ceftazidime in internal medicine in Japan.
Shimada K
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():395-7. PubMed ID: 6225765
[TBL] [Abstract][Full Text] [Related]
3. A comparison of ceftazidime and tobramycin in the treatment of complicated urinary tract infections.
Cox CE
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():47-52. PubMed ID: 6352654
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of ceftazidime in Japan.
Ishibiki K
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():123-30. PubMed ID: 6225760
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime therapy for serious infections.
Bint AJ; Constable J; Patton KR; Constable FL
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():115-21. PubMed ID: 6352613
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
[TBL] [Abstract][Full Text] [Related]
7. Complicated urinary tract infections treated with ceftazidime and tobramycin: a comparative study.
Madsen PO; Frimodt-Møller PC
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():77-9. PubMed ID: 6352658
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of ceftazidime. Treatment of serious infection due to multiresistant Pseudomonas and other gram-negative bacteria.
Scully BE; Neu HC
Arch Intern Med; 1984 Jan; 144(1):57-62. PubMed ID: 6419690
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ceftazidime in the treatment of severe bacterial infection.
Bouza E; Hellín T; Sanz-Hospital J; Rodríguez-Creixems M; Loza E; Martínez-Beltrán J
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():153-9. PubMed ID: 6352616
[TBL] [Abstract][Full Text] [Related]
10. Ceftazidime treatment in intensive care patients.
van Dalen R; Muytjens HL; Gimbrère JS
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
Kawamura N; Ohkoshi M; Okada K; Kumamoto Y; Miyamoto S; Niijima T; Kishi Y; Nishimura Y; Saito I; Yuge J
Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime in the treatment of complicated respiratory and urinary tract infections.
Loebis LH; Williams KJ
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the usefulness of a novel injectable cephalosporin, E1040, and ceftazidime for management of complicated urinary tract infections caused by Pseudomonas aeruginosa and Proteus mirabilis by using the rat urolithiasis model.
Satoh M; Munakata K; Takeuchi H; Yoshida O
Antimicrob Agents Chemother; 1992 Jul; 36(7):1580-3. PubMed ID: 1510458
[TBL] [Abstract][Full Text] [Related]
14. A random comparative trial of 0.25, 0.5 and 1.0 g ceftazidime twice daily in urinary tract infection.
Gentry LO; Douthit MB; Childs SJ; Madsen PO
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():53-7. PubMed ID: 6352655
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on ceftibuten in the urinary field infection].
Suzuki K; Nagata Y; Horiba M
Jpn J Antibiot; 1990 Nov; 43(11):2003-10. PubMed ID: 2287061
[TBL] [Abstract][Full Text] [Related]
16. Ceftazidime in severe infections: a Swiss multicentre study.
Francioli P; Clément M; Geroulanos S; von Graevenitz A; Luthy R; Regamey C; Stalder H; Vogt M; Waldvogel FA
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():139-46. PubMed ID: 6225761
[TBL] [Abstract][Full Text] [Related]
17. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620
[TBL] [Abstract][Full Text] [Related]
18. Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp.
Rusconi F; Assael BM; Florioli A; Zaffaroni G
Antimicrob Agents Chemother; 1984 Mar; 25(3):395-7. PubMed ID: 6372686
[TBL] [Abstract][Full Text] [Related]
19. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
Carmeli Y; Armstrong J; Laud PJ; Newell P; Stone G; Wardman A; Gasink LB
Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
[TBL] [Abstract][Full Text] [Related]
20. Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa--a comparison of the efficacy of ceftazidime with that of netilmicin.
Graninger W; Ho I; Francesconi M; Schmidbauer C; Egger T
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():323-4. PubMed ID: 19803008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
